Menkul kıymet kaydı · arşivlenmiş çeyrek
CGEM
Cullinan Therapeutics, Inc. · Healthcare · Biotechnology
65Takip edilen yatırımcılar
+1Δ sahipler
21.69MTutulan hisseler
$224.52MRaporlanan değer
+1Yeni pozisyonlar
−0Çıkışlar
Momentum girdileri (karşılaştırılabilir yöneticiler):
hissedar genişliği +1.6% ·
pay akışı +1.4% ·
net yeni pozisyonlar +1.5%
· formül
Geniş birikim: daha fazla hissedar arasında artan hisseler
Tüm sahiplik rakamları: yalnızca izlenen 13F yöneticileri, adi hisse senedi pozisyonları, raporlama dönemi Q4 2025
Zaman içinde sahiplik
| Çeyrek | Hissedarlar | Δ | Hisseler | Raporlanan değer | Yeni | Çıkışlar |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 10.21K | $157,847 | n/a | −1 |
| Q2 2026 | 77 | +7 | 28.05M | $510.52M | +11 | −4 |
| Q1 2026 | 73 | +7 | 24.59M | $348.81M | +10 | −3 |
| Q4 2025 | 65 | +1 | 21.69M | $224.52M | +1 | n/a |
| Q3 2025 | 17 | +1 | 15.39M | $91.26M | +1 | n/a |
| Q2 2025 | 13 | 0 | 14.48M | $109.06M | +1 | −1 |
| Q1 2025 | 10 | -1 | 7.69M | $58.25M | n/a | −1 |
| Q4 2024 | 11 | 0 | 8.98M | $109.41M | n/a | n/a |
| Q3 2024 | 10 | +1 | 6.86M | $114.80M | +1 | n/a |
| Q2 2024 | 9 | n/a | 7.12M | $124.19M | n/a | n/a |
Kimler elinde bulunduruyor · Q4 2025
| # | Yönetici | Hisseler | Δ hisseler | Değer | Ağırlıkları | Tutulan | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 4.40M | +5.5% | $45.54M | 0.0% | ▲ Add | 3 | SEC ↗ ×11 |
| 2 | The Vanguard Group ✦ (pasif) | 3.30M | +12.1% | $34.14M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (pasif) | 2.20M | +31.0% | $22.74M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasif) | 1.30M | +0.5% | $13.48M | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 5 | Dimensional Fund Advisors Lp | 848.77K | n/a | $8.78M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 6 | Morgan Stanley ✦ | 766.93K | +91.7% | $7.94M | 0.0% | ▲ Add | 2 | SEC ↗ ×8 |
| 7 | Goldman Sachs Group ✦ | 721.86K | -26.6% | $7.47M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 8 | Renaissance Technologies ✦ | 631.71K | +19.3% | $6.54M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 9 | Deutsche Bank Ag\ | 586.64K | n/a | $6.07M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Nuveen, LLC | 579.10K | n/a | $5.99M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | Two Sigma Investments ✦ | 470.53K | +688.5% | $4.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Charles Schwab Investment… | 436.27K | n/a | $4.52M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Northern Trust Corp | 421.63K | n/a | $4.36M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 14 | Marshall Wace ✦ | 414.36K | +40.2% | $4.29M | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 15 | Millennium Management ✦ | 362.50K | -34.1% | $3.75M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 360.16K | Yeni | $3.73M | 0.0% | New | 1 | SEC ↗ |
| 17 | Bank Of America Corp /De/ | 346.31K | n/a | $3.58M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 18 | AQR Capital Management ✦ | 281.48K | +42.2% | $2.91M | 0.0% | ▲ Add | 3 | SEC ↗ ×6 |
| 19 | UBS Group AG | 271.74K | n/a | $2.81M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 20 | Barclays Plc | 269.65K | n/a | $2.79M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 21 | Connor, Clark & Lunn Investment… | 244.02K | n/a | $2.53M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Citigroup Inc | 240.46K | n/a | $2.49M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 23 | Jane Street Group, Llc | 186.84K | n/a | $1.93M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 24 | Wellington Management ✦ | 159.75K | -5.0% | $1.65M | 0.0% | ▼ Trim | 7 | SEC ↗ ×3 |
| 25 | Assenagon Asset Management S.A. | 158.75K | n/a | $1.64M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 147.06K | +130.7% | $1.52M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 27 | Bank of New York Mellon Corp | 144.93K | n/a | $1.50M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 28 | American Century Companies Inc | 142.76K | n/a | $1.48M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Invesco Ltd. | 130.32K | n/a | $1.35M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 30 | Qube Research & Technologies Ltd | 119.29K | n/a | $1.23M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 110.32K | -94.4% | $1.14M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 32 | Hrt Financial Lp | 84.07K | n/a | $870,000 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Squarepoint Ops LLC | 75.82K | n/a | $784,737 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Rhumbline Advisers | 67.24K | n/a | $695,924 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Wells Fargo & Company/Mn | 60.51K | n/a | $626,320 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Swiss National Bank | 58.30K | n/a | $603,405 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Mariner, LLC | 49.13K | n/a | $508,208 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | UBS AM, a distinct business unit of… | 48.05K | n/a | $497,328 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 39 | Quantinno Capital Management LP | 48.00K | n/a | $496,810 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Alliancebernstein L.P. | 47.63K | n/a | $492,971 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | T. Rowe Price ✦ | 47.19K | +9.1% | $489,000 | 0.0% | ▲ Add | 7 | SEC ↗ |
| 42 | Creative Planning | 39.89K | n/a | $412,862 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Susquehanna International Group, Llp | 39.82K | n/a | $412,158 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Bnp Paribas Financial Markets | 39.45K | n/a | $408,318 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | California State Teachers… | 30.80K | n/a | $318,770 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Legal & General Group Plc | 28.63K | n/a | $296,299 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 47 | MIRAE ASSET GLOBAL ETFS HOLDINGS… | 28.66K | n/a | $295,073 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 48 | Russell Investments Group, Ltd. | 24.41K | n/a | $252,631 | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 49 | Janus Henderson Group Plc | 18.53K | n/a | $191,394 | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Manufacturers Life Insurance… | 16.82K | n/a | $174,108 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | D. E. Shaw & Co. ✦ | 14.37K | -43.9% | $148,678 | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 52 | Simplex Trading, Llc | 13.25K | n/a | $137,168 | 0.0% | n/c | 1 | SEC ↗ |
| 53 | New York State Common Retirement… | 12.92K | n/a | $133,701 | 0.0% | n/c | 1 | SEC ↗ |
| 54 | ProShare Advisors LLC | 12.49K | n/a | $129,261 | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Tudor Investment Corp Et Al | 10.13K | n/a | $104,825 | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Zurcher Kantonalbank (Zurich… | 9.91K | n/a | $102,558 | 0.0% | n/c | 1 | SEC ↗ |
| 57 | Fidelity (FMR) ✦ | 4.60K | +375.0% | $47,586 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 58 | Cwm, Llc | 3.88K | n/a | $40,000 | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Mirae Asset Global Investments Co.… | 2.87K | n/a | $29,715 | 0.0% | n/c | 1 | SEC ↗ |
| 60 | Royal Bank Of Canada | 1.55K | n/a | $16,000 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 61 | Us Bancorp \De\ | 483 | n/a | $4,999 | 0.0% | n/c | 1 | SEC ↗ |
| 62 | Osaic Holdings, Inc. | 243 | n/a | $2,515 | 0.0% | n/c | 1 | SEC ↗ |
| 63 | Optiver Holding B.V. | 200 | n/a | $2,070 | 0.0% | n/c | 1 | SEC ↗ |
| 64 | Daiwa Securities Group Inc. | 218 | n/a | $2,000 | 0.0% | n/c | 1 | SEC ↗ |
| 65 | Pnc Financial Services Group, Inc. | 5 | n/a | $52 | 0.0% | n/c | 1 | SEC ↗ |
"Yöneticinin ağırlığı" = pozisyonun, yöneticinin raporlanan 13F hisse senedi değeri içindeki payı: kanaat ölçüsü. ✦ = seçilmiş yönetici.
Yeni alıcılar
| Point72 Asset Management | $3.73M | 0.0% |
Çıkıldı
| Bu çeyrekte takip edilen çıkış yok. |
Tam piyasa bağlamı: TÜM 13F filers'ları genelinde (SEC yapılandırılmış veri, Q1 2026): 172 sahipler, 65.27M hisseler, $895.39M raporlanan. Bu, yukarıdaki takip edilen evren rakamlarından farklı, daha eski bir döneme aittir ve ikisi hiçbir zaman birbirine karıştırılmaz.
Sık birlikte tutulan
Bu menkul kıymetin takip edilen sahiplerinin en sık birlikte tuttuğu diğer varlıklar: ortak sahiplik sayıları, temel ilişkiler değil.
Açık piyasa alımları (P)
Kapsama penceremizde açık piyasa içeriden alım işlemi yok.
Açık piyasa satışları (S)
Sep 08
Michaelson Jennifer
Officer · 8.00K hisse · $172,560
Aug 13
Michaelson Jennifer
Officer · 30.00K hisse · $607,800
Ödüller, kullanımlar ve vergi stopajı hiçbir zaman alım veya satım olarak sayılmaz. Metodoloji
Aug 14
SC 13G/A: BIOTECHNOLOGY VALUE FUND L P
Aug 14
SC 13G: PRICE T ROWE ASSOCIATES INC /MD/
Aug 07
SC 13G: STATE STREET CORP
Kaynak: Ayrıştırılmış 13F adi hisse senedi pozisyonlarından elde edilen sahiplik bilgileri (takip edilen evren, değişiklikler için karşılaştırılabilir setler); içeriden işlem satırları Form 3/4/5'ten; paylar Schedule 13D/13G'den; her dosyalama SEC EDGAR'daki orijinaline bağlantı içerir.
Raporlama dönemi: Q4 2025 ·
Metodoloji ·
Bunu API aracılığıyla edinin